FAM172A: A Potential Drug Target and Biomarker for Diseases (G83989)

Target Name: FAM172A

NCBI ID: G83989

FAM172A: A Potential Drug Target and Biomarker for Diseases

FAM172A, also known as FAM172A variant 1, is a gene that has been identified as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The FAM172A gene is located on chromosome 16 and encodes a protein known as FAM172A, which is a key regulator of cell growth and differentiation. The FAM172A gene has been implicated in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of the FAM172A gene is its potential as a drug target. By targeting the FAM172A protein, researchers may be able to develop new treatments for diseases that are currently difficult to treat or have no known treatment options. Additionally, the FAM172A gene has also been identified as a potential biomarker, which could be used to diagnose and monitor the progression of certain diseases.

The FAM172A gene has been shown to be involved in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that high levels of FAM172A are associated with an increased risk of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. Additionally, the FAM172A gene has also been implicated in the development of certain autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

In addition to its potential as a drug target or biomarker, the FAM172A gene also has important implications for our understanding of gene regulation and disease. By studying the FAM172A gene, researchers may be able to gain new insights into how genes contribute to the development and progression of disease. This knowledge could ultimately lead to the development of new treatments and therapies for a variety of diseases.

Overall, the FAM172A gene is a promising target for drug development and research into the underlying causes of disease. Further studies are needed to fully understand its role in disease and to develop effective treatments.

Protein Name: Family With Sequence Similarity 172 Member A

Functions: Plays a role in the regulation of alternative splicing, by interacting with AGO2 and CHD7. Seems to be required for stabilizing protein-protein interactions at the chromatin-spliceosome interface. May have hydrolase activity

More Common Targets